Correction: An MDM2 degrader for treatment of acute leukemias

被引：0
|
作者：
Bridget K. Marcellino
Xiaobao Yang
H. Ümit Kaniskan
Claudia Brady
He Chen
Karie Chen
Xing Qiu
Cara Clementelli
Lauren Herschbein
Zhijun Li
Sebastian Elghaity-Beckley
Joann Arandela
Brianna Kelly
Ronald Hoffman
Jing Liu
Yue Xiong
Jian Jin
Alan H. Shih
机构：
[1] Icahn School of Medicine at Mount Sinai (ISMMS),Department of Medicine, Division of Hematology Oncology and Tisch Cancer Institute (TCI)
[2] Tisch Cancer Institute (TCI) Icahn School of Medicine at Mount Sinai (ISMMS),Mount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences, Oncological Sciences, and Neuroscience
[3] New York,undefined
[4] University of North Carolina at Chapel Hill,undefined
[5] Cullgen Inc.,undefined
来源：
Leukemia | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1764 / 1765
页数：1
相关论文
共 50 条
  • [31] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Argentini, M
    Barboule, N
    Wasylyk, B
    ONCOGENE, 2001, 20 (11) : 1267 - 1275
  • [32] Rescue of Mdm4-deficient mice by Mdm2 reveals functional overlap of Mdm2 and Mdm4 in development
    Heather A Steinman
    Kathleen M Hoover
    Marilyn L Keeler
    Arthur T Sands
    Stephen N Jones
    Oncogene, 2005, 24 : 7935 - 7940
  • [33] MDM2 variant in tumorigenesis
    Vogan, K
    NATURE GENETICS, 2005, 37 (01) : 17 - 17
  • [34] Mdm2: The Ups and Downs
    Tamar Juven-Gershon
    Moshe Oren
    Molecular Medicine, 1999, 5 : 71 - 83
  • [35] The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcoma
    Ichikawa, Jiro
    Kawasaki, Tomonori
    Onohara, Kojiro
    Kanno, Satoshi
    Wako, Masanori
    Ochiai, Satoshi
    Aoki, Kaoru
    Haro, Hirotaka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [36] Posttransiational modification of MDM2
    Meek, DW
    Knippschild, U
    MOLECULAR CANCER RESEARCH, 2003, 1 (14) : 1017 - 1026
  • [37] MDM2 in breast cancer
    Masakazu Toi
    Shigehira Saji
    Akio Suzuki
    Yutaka Yamamoto
    Takeshi Tominaga
    Breast Cancer, 1997, 4 (4) : 264 - 268
  • [38] Conditional inactivation of Mdm2
    Mary Ellen Perry
    Susan Mendrysa
    Nature Genetics, 2001, 27 (Suppl 4) : 78 - 79
  • [39] Mdm2 as a chromatin modifier
    Wienken, Magdalena
    Moll, Ute M.
    Dobbelstein, Matthias
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2017, 9 (01) : 74 - 80
  • [40] Functions of the MDM2 oncoprotein
    D. A. Freedman
    L. Wu
    A. J. Levine
    Cellular and Molecular Life Sciences CMLS, 1999, 55 : 96 - 107
12345